Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,213.83
-1,025.95(-2.00%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

2.7300

+0.0100

(+0.37%)

At close: 04:00PM EDT

2.7300

0.00

(0.00%)

After hours:

04:20PM EDT

Insider roster

Insider transactions

Insider roster

Individual or entity	Most-recent transaction	Date	Shares owned as of transaction date
ABRAMS MICHAEL J Officer	Conversion of Exercise of derivative security	15 Aug 2016	42,097
COLLIER WILLIAM H. Chief Executive Officer	Stock Award(Grant)	31 Jan 2023	216,500
HASTINGS DAVID C Chief Financial Officer	Sale	01 Feb 2024	181,907
HOWARD ELIZABETH ANN Officer	Stock Award(Grant)	31 Jan 2023	86,024
MC ELHAUGH MICHAEL JOHN Chief Executive Officer	Sale	01 Feb 2024	1,504,790
MURRAY MARK J Director	Conversion of Exercise of derivative security	27 Nov 2018	341,396
NAFTZGER J CHRISTOPHER General Counsel	Stock Award(Grant)	31 Jan 2024	95,100
ROIVANT SCIENCES LTD. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	17 Oct 2021	38,847,500
SIMS KAREN Officer	Sale	01 Feb 2024	125,542
SOFIA MICHAEL JOSEPH Officer	Sale	01 Feb 2024	1,652,280
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.